Search filters

Authors whose works are in public domain in at least one jurisdiction

List of works by Ravi Salgia

1556. Infectious Disease Complications with Use of Checkpoint Inhibitors in Solid Organ Malignancies

scholarly article by Kellie Komoda et al published November 2018 in Open Forum Infectious Diseases

2'-Hydroxyflavanone effectively targets RLIP76-mediated drug transport and regulates critical signaling networks in breast cancer.

scientific article published on 6 April 2018

2-methoxyestradiol alters cell motility, migration, and adhesion

scientific article published on 13 March 2003

A Novel Classification of Lung Cancer into Molecular Subtypes ⬇️

scientific article published on February 21, 2012

A fragment of paxillin binds the alpha 4 integrin cytoplasmic domain (tail) and selectively inhibits alpha 4-mediated cell migration

scientific article (publication date: 7 June 2002)

A multicenter phase I study of pazopanib in combination with paclitaxel in first-line treatment of patients with advanced solid tumors

scientific article published on 10 December 2014

A multicenter phase II study of ganetespib monotherapy in patients with genotypically defined advanced non-small cell lung cancer

scientific article published on 03 April 2013

A new PET/CT volumetric prognostic index for non-small cell lung cancer

scientific article published on 9 April 2015

A new hope for precision medicine

scientific article

A novel small molecule met inhibitor induces apoptosis in cells transformed by the oncogenic TPR-MET tyrosine kinase ⬇️

scientific article published on September 1, 2003

A personalized treatment for lung cancer: molecular pathways, targeted therapies, and genomic characterization

scientific article published on January 2014

A phase I open-label dose-escalation study of the anti-HER3 monoclonal antibody LJM716 in patients with advanced squamous cell carcinoma of the esophagus or head and neck and HER2-overexpressing breast or gastric cancer

scientific article published on 12 September 2017

A randomized phase II study of LY2510924 and carboplatin/etoposide versus carboplatin/etoposide in extensive-disease small cell lung cancer

scientific article published on 31 December 2016

A review of topoisomerase inhibition in lung cancer

scientific article published on 29 December 2006

A safety assessment of crizotinib in the treatment of ALK-positive NSCLC patients

scientific article published on 07 February 2015

A selective small molecule c-MET Inhibitor, PHA665752, cooperates with rapamycin

scientific article published in March 2005

A selective small molecule inhibitor of c-Met, PHA665752, inhibits tumorigenicity and angiogenesis in mouse lung cancer xenografts

scientific article published on April 2007

ATP6S1 elicits potent humoral responses associated with immune-mediated tumor destruction

scientific article

AXL mediates resistance to cetuximab therapy

scientific article

Activating the expression of human K-rasG12D stimulates oncogenic transformation in transgenic goat fetal fibroblast cells

scientific article

Activation of HGF/c-Met pathway contributes to the reactive oxygen species generation and motility of small cell lung cancer cells

scientific article published on 23 February 2007

Activation of MET via diverse exon 14 splicing alterations occurs in multiple tumor types and confers clinical sensitivity to MET inhibitors

scientific article

Activation of the PI3K/mTOR pathway by BCR-ABL contributes to increased production of reactive oxygen species

scientific article

Activity and safety of brigatinib in ALK-rearranged non-small-cell lung cancer and other malignancies: a single-arm, open-label, phase 1/2 trial

scientific article published on 7 November 2016

Activity and safety of crizotinib in patients with ALK-positive non-small-cell lung cancer: updated results from a phase 1 study

scientific article published on 04 September 2012

Activity of XL184 (Cabozantinib), an Oral Tyrosine Kinase Inhibitor, in Patients With Medullary Thyroid Cancer ⬇️

scientific article published on May 23, 2011

Activity of crizotinib (PF02341066), a dual mesenchymal-epithelial transition (MET) and anaplastic lymphoma kinase (ALK) inhibitor, in a non-small cell lung cancer patient with de novo MET amplification

scientific article

Acute myeloid leukemia cells require 6-phosphogluconate dehydrogenase for cell growth and NADPH-dependent metabolic reprogramming

scientific article published on 28 June 2017

An E3 ubiquitin ligase: c-Cbl: a new therapeutic target of lung cancer

scientific article

Analysis of 1,115 patients tested for MET amplification and therapy response in the MD Anderson Phase I Clinic.

scientific article published on 17 October 2014

Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer

scientific article

Autotaxin induces lung epithelial cell migration through lysoPLD activity-dependent and -independent pathways ⬇️

scientific article published on October 1, 2011

Biomarker discovery in lung cancer--promises and challenges of clinical proteomics

scientific article published on May 2007

Biomarkers in lung cancer: from early detection to novel therapeutics and decision making

scientific article published on December 2008

Biopsy-free circulating tumor DNA assay identifies actionable mutations in lung cancer

scientific article published on September 2016

Bortezomib for patients with advanced-stage bronchioloalveolar carcinoma: a California Cancer Consortium Phase II study (NCI 7003).

scientific article published on October 2011

Brain metastases in non-small-cell lung cancer: better outcomes through current therapies and utilization of molecularly targeted approaches

scientific article

C. elegans and mutants with chronic nicotine exposure as a novel model of cancer phenotype

scientific article published on 17 November 2015

C. elegans as a model organism for in vivo screening in cancer: effects of human c-Met in lung cancer affect C. elegans vulva phenotypes

scientific article published on 05 March 2008

CBL is frequently altered in lung cancers: its relationship to mutations in MET and EGFR tyrosine kinases

scientific article

CD14+S100A9+ Myeloid-derived Suppressor Cells Portend Decreased Survival in Patients with Advanced Lung Cancer ⬇️

scientific article published on November 15, 2012

CD2 molecules redistribute to the uropod during T cell scanning: implications for cellular activation and immune surveillance

scientific article

CD44 Regulates Hepatocyte Growth Factor-mediated Vascular Integrity

scientific article published in Journal of Biological Chemistry

Canonical and alternative transcript expression of PAX6 and CXCR4 in pancreatic cancer

scientific article

Capecitabine and Celecoxib as a Promising Therapy for Thymic Neoplasms

scientific article published on 26 June 2017

Cell Motility, Adhesion, Homing, and Migration Assays in the Studies of Tyrosine Kinases

scientific article published on January 1, 2003

Characterization of NOL7 gene point mutations, promoter methylation, and protein expression in cervical cancer

scientific article published on January 2012

Circulating tumor cells and serum tumor biomarkers in small cell lung cancer

scientific article

Combined Checkpoint Inhibition and Chemotherapy: New Era of 1-Line Treatment for Non-Small-Cell Lung Cancer

Combined MET inhibition and topoisomerase I inhibition block cell growth of small cell lung cancer

scientific article published on 10 December 2013

Comprehensive Genomic Profiling Identifies a Subset of Crizotinib-Responsive ALK-Rearranged Non-Small Cell Lung Cancer Not Detected by Fluorescence In Situ Hybridization

scientific article published on 31 May 2016

Comprehensive genetic testing identifies targetable genomic alterations in most patients with non-small cell lung cancer, specifically adenocarcinoma, single institute investigation

scientific article published on 26 February 2016

Concerted potent humoral immune responses to autoantigens are associated with tumor destruction and favorable clinical outcomes without autoimmunity

scientific article

Concurrent EGFR Mutation and ALK Translocation in Non-Small Cell Lung Cancer

scientific article published on 26 February 2016

Correction: CBL Is Frequently Altered in Lung Cancers: Its Relationship to Mutations in MET and EGFR Tyrosine Kinases.

scientific article

Correction: Genomic mutation-driven metastatic breast cancer therapy: a single center experience

scientific article published on 22 September 2017

Critical Role for the Receptor Tyrosine Kinase EPHB4 in Esophageal Cancers ⬇️

scientific article published on October 24, 2012

Critical Role of S1PR1 and Integrin β4 in HGF/c-Met-mediated Increases in Vascular Integrity ⬇️

scientific article published on December 4, 2012

Crizotinib (PF02341066) as a ALK /MET inhibitor- Special Emphasis as a Therapeutic Drug Against Lung Cancer

scientific article

DIFFERENTIAL SERUM LEVEL OF SPECIFIC HAPTOGLOBIN ISOFORMS IN SMALL CELL LUNG CANCER.

scientific article

Development of PD-1 and PD-L1 inhibitors as a form of cancer immunotherapy: a comprehensive review of registration trials and future considerations

scientific article

Development of The American Association for Thoracic Surgery guidelines for low-dose computed tomography scans to screen for lung cancer in North America: recommendations of The American Association for Thoracic Surgery Task Force for Lung Cancer Sc

scientific article

Diagnostic challenges in non-small-cell lung cancer: an integrated medicine approach

scientific article

Differential expression and signaling of CBL and CBL-B in BCR/ABL transformed cells

scientific article

Differential expression of RON in small and non-small cell lung cancers

scientific article published on 14 May 2012

Differential responsiveness of MET inhibition in non-small-cell lung cancer with altered CBL.

scientific article

Dose-finding and pharmacokinetic study to optimize the dosing of irinotecan according to the UGT1A1 genotype of patients with cancer

scientific article

Dramatic antitumor effects of the dual MET/RON small-molecule inhibitor LY2801653 in non-small cell lung cancer

scientific article published on 4 December 2013

Durable complete response of metastatic gastric cancer with anti-Met therapy followed by resistance at recurrence

scientific article

EGFR-targeted therapeutics: focus on SCCHN and NSCLC.

scientific article

Effect of crizotinib on overall survival in patients with advanced non-small-cell lung cancer harbouring ALK gene rearrangement: a retrospective analysis

scientific article

Effective growth-suppressive activity of maternal embryonic leucine-zipper kinase (MELK) inhibitor against small cell lung cancer

scientific article published on 10 February 2016

Effective osimertinib treatment in a patient with discordant T790 M mutation detection between liquid biopsy and tissue biopsy

scientific article

Efficacy and safety of bevacizumab plus erlotinib for patients with recurrent ovarian, primary peritoneal, and fallopian tube cancer: a trial of the Chicago, PMH, and California Phase II Consortia

scientific article published on 18 April 2008

Empowering survivors after colorectal and lung cancer treatment: Pilot study of a Self-Management Survivorship Care Planning intervention

scientific article published on 19 June 2017

Engineering Synthetic Antibody Inhibitors Specific for LD2 or LD4 Motifs of Paxillin

scientific article published on 16 June 2015

EphA2 mutation in lung squamous cell carcinoma promotes increased cell survival, cell invasion, focal adhesions, and mammalian target of rapamycin activation

scientific article published on April 2010

EphB4 as a therapeutic target in mesothelioma ⬇️

scientific article published on May 30, 2013

EphB4: A promising target for upper aerodigestive malignancies

scientific article published on 21 January 2018

Epidermal growth factor receptor - mediated signal transduction in the development and therapy of gliomas

scientific article published on December 2006

Epidermal growth factor receptor mutations and susceptibility to targeted therapy in lung cancer

scientific article

Erlotinib plus bevacizumab in previously treated patients with malignant pleural mesothelioma

scientific article published in August 2008

Erratum to: Targeting ALK: a promising strategy for the treatment of non-small cell lung cancer, non-Hodgkin’s lymphoma, and neuroblastoma

scholarly article published in Targeted oncology

Ethnic differences and functional analysis of MET mutations in lung cancer

scientific article published on September 2009

Evaluation of a novel rash scale and a serum proteomic predictor in a randomized phase II trial of sequential or concurrent cetuximab and pemetrexed in previously treated non-small cell lung cancer

scientific article

Exosomal miRNAs species in the blood of small cell and non-small cell lung cancer patients.

scientific article

Expression and mutational analysis of MET in human solid cancers

scientific article published on December 2008

Expression and mutational analysis of c-CBL and its relationship to the MET receptor in head and neck squamous cell carcinoma

scientific article published on 26 May 2016

Expression of Siva-1 protein or its putative amphipathic helical region enhances cisplatin-induced apoptosis in breast cancer cells: effect of elevated levels of BCL-2

scientific article

Expression of the EPHB4 receptor tyrosine kinase in head and neck and renal malignancies--implications for solid tumors and potential for therapeutic inhibition

scientific article published on 13 November 2014

Expression patterns of PAX5, c-Met, and paxillin in neuroendocrine tumors of the lung ⬇️

scientific article published on November 1, 2010

FAK and paxillin, two potential targets in pancreatic cancer

scientific article

Fibroblast growth factor signaling and inhibition in non-small cell lung cancer and their role in squamous cell tumors

scientific article published on 8 April 2014

Flow cytometric determination of lipid peroxidation using fluoresceinated phosphoethanolamine

scientific article

Focal Adhesion Kinase a Potential Therapeutic Target for Pancreatic Cancer and Malignant Pleural Mesothelioma

scientific article published on 5 January 2018

Functional EGFR Germline Polymorphisms May Confer Risk for EGFR Somatic Mutations in Non–Small Cell Lung Cancer, with a Predominant Effect on Exon 19 Microdeletions ⬇️

scientific article published on February 3, 2011

Functional analysis of c-Met/hepatocyte growth factor pathway in malignant pleural mesothelioma

scientific article published on January 2006

Functional expression and mutations of c-Met and its therapeutic inhibition with SU11274 and small interfering RNA in non-small cell lung cancer.

scientific article published on February 2005

Fyn Is Downstream of the HGF/MET Signaling Axis and Affects Cellular Shape and Tropism in PC3 Cells ⬇️

scientific article published on May 15, 2011

Fyn: a novel molecular target in cancer

scientific article

Gefitinib response of erlotinib-refractory lung cancer involving meninges--role of EGFR mutation

scientific article published in January 2006

Gemcitabine-induced radiation recall

scientific article

Generation of Comprehensive Thoracic Oncology Database - Tool for Translational Research ⬇️

scientific article published on January 22, 2011

Genomic mutation-driven metastatic breast cancer therapy: a single center experience

scientific article

Geographic variation in radiologist capacity and widespread implementation of lung cancer CT screening

scientific article published on 12 August 2014

HABP2 is a Novel Regulator of Hyaluronan-Mediated Human Lung Cancer Progression

scientific article published on 21 July 2015

Haptoglobin alpha-subunit and hepatocyte growth factor can potentially serve as serum tumor biomarkers in small cell lung cancer.

scientific article

Heuristic value-based framework for lung cancer decision-making.

scientific article published on 6 July 2018

Hypofractionated Image-Guided Radiation Therapy for Patients with Limited Volume Metastatic Non-small Cell Lung Cancer ⬇️

scientific article published on February 1, 2012

Inhibiting crosstalk between MET signaling and mitochondrial dynamics and morphology: a novel therapeutic approach for lung cancer and mesothelioma

scientific article

Inhibition of MET receptor tyrosine kinase and its ligand hepatocyte growth factor

scientific article published on December 2012

Inhibition of epidermal growth factor receptor signaling in malignant pleural mesothelioma

scientific article published on September 2002

Inhibition of mitochondrial fission prevents cell cycle progression in lung cancer ⬇️

scientific article published on February 9, 2012

Initial Clinical Sensitivity and Acquired Resistance to MET Inhibition in MET-Mutated Papillary Renal Cell Carcinoma ⬇️

scientific article published on April 22, 2013

Integrative analysis of head and neck cancer identifies two biologically distinct HPV and three non-HPV subtypes

scientific article published on 9 December 2014

Integrin-dependent protein tyrosine phosphorylation is a key regulatory event in collagen-IV-mediated adhesion and proliferation of human lung tumor cell line, Calu-1.

scientific article published on August 2004

KRAS in Non-Small-Cell Lung Cancer-Reply

scientific article published on 21 July 2016

Key signaling pathways and targets in lung cancer therapy.

scientific article published on February 2007

Lack of Association of C-Met-N375S Sequence Variant with Lung Cancer Susceptibility and Prognosis ⬇️

scientific article published on June 14, 2013

Lipopolysaccharide-induced phosphorylation of c-Met tyrosine residue 1003 regulates c-Met intracellular trafficking and lung epithelial barrier function ⬇️

scientific article published on April 26, 2013

Loss of H2B monoubiquitination is associated with poor-differentiation and enhanced malignancy of lung adenocarcinoma

scientific article published on 8 May 2017

Lung cancer-a fractal viewpoint

scientific article

Lung carcinoma in African Americans

scientific article published on February 2007

Lysophosphatidic acid modulates c-Met redistribution and hepatocyte growth factor/c-Met signaling in human bronchial epithelial cells through PKC delta and E-cadherin

scientific article

MET As a Possible Target for Non–Small-Cell Lung Cancer ⬇️

scientific article published on February 11, 2013

MET amplification identifies a small and aggressive subgroup of esophagogastric adenocarcinoma with evidence of responsiveness to crizotinib

scientific article published on 31 October 2011

MET and PI3K/mTOR as a potential combinatorial therapeutic target in malignant pleural mesothelioma

scientific article

MET and phosphorylated MET as potential biomarkers in lung cancer

scientific article published in January 2011

MET as a drug target.

scientific article published in June 2015

MET as a target for treatment of chest tumors

scientific article published on 30 July 2008

MET in Lung Cancer: Biomarker Selection Based on Scientific Rationale

scientific article

MET in the Driver's Seat: Exon 14 Skipping Mutations as Actionable Targets in Lung Cancer

scientific article published in September 2016

MET molecular mechanisms and therapies in lung cancer

scientific article

MET pathway as a therapeutic target

scientific article published on April 2009

MET receptor tyrosine kinase

scientific article

MET, HGF, EGFR, and PXN gene copy number in lung cancer using DNA extracts from FFPE archival samples and prognostic significance

scientific article published on January 2009

MET/PKCbeta expression correlate with metastasis and inhibition is synergistic in lung cancer

scientific article published on January 2009

Managing Patients With Relapsed Small-Cell Lung Cancer.

scientific article

Mechanisms of Metastasis as Related to Receptor Tyrosine Kinases in Small-Cell Lung Cancer ⬇️

scientific article published on January 1, 2003

Melanoma proteoglycan modifies gene expression to stimulate tumor cell motility, growth, and epithelial-to-mesenchymal transition

scientific article published on 08 September 2009

Met gene amplification and protein hyperactivation is a mechanism of resistance to both first and third generation EGFR inhibitors in lung cancer treatment

scientific article published on 19 July 2016

Methylnaltrexone potentiates the anti-angiogenic effects of mTOR inhibitors

scientific article

Mitochondrial dynamics: biology and therapy in lung cancer

scientific article published on 22 March 2014

Modeling small cell lung cancer (SCLC) biology through deterministic and stochastic mathematical models.

scientific article

Modulation of c-Kit/SCF pathway leads to alterations in topoisomerase-I activity in small cell lung cancer

scientific article

Modulation of the c-Met/hepatocyte growth factor pathway in small cell lung cancer.

scientific article published on February 2002

Molecular alterations in lung cancer. Impact on prognosis.

scientific article

Molecular and cellular biology of small cell lung cancer

scientific article

Molecular biology of malignant mesothelioma: a review

scientific article

Molecular biomarkers for future screening of lung cancer ⬇️

scientific article published on July 25, 2013

Molecular pathways and therapeutic targets in lung cancer

scientific article

Molecular profiling of metastatic colorectal tumors using next-generation sequencing: a single-institution experience

scientific article published on 2 February 2017

Molecularly targeted therapies in non-small-cell lung cancer annual update 2014

scientific article

Multicenter Phase II Trial of Motexafin Gadolinium and Pemetrexed for Second-Line Treatment in Patients with Non-small Cell Lung Cancer ⬇️

scientific article published on April 1, 2011

Multiple Endocrine Disruption by the MET/ALK Inhibitor Crizotinib in Patients With Non–small Cell Lung Cancer ⬇️

scientific article published on October 1, 2015

Mutation testing for directing upfront targeted therapy and post-progression combination therapy strategies in lung adenocarcinoma

scientific article published on 03 May 2016

Non-receptor tyrosine kinase inhibitors in lung cancer

scientific article

Non-small cell lung cancer is susceptible to induction of DNA damage responses and inhibition of angiogenesis by telomere overhang oligonucleotides

scientific article published on 14 September 2013

Novel EPHB4 Receptor Tyrosine Kinase Mutations and Kinomic Pathway Analysis in Lung Cancer

scientific article published on 15 June 2015

Novel functional germline variants in the VEGF receptor 2 gene and their effect on gene expression and microvessel density in lung cancer

scientific article

Novel oncogenic mutations of CBL in human acute myeloid leukemia that activate growth and survival pathways depend on increased metabolism

scientific article

Novel targets for therapeutic agents in small cell lung cancer

scientific article published on March 2004

Novel therapies in lung cancer

scientific article

Nuclear EGFR protein expression predicts poor survival in early stage non-small cell lung cancer ⬇️

scientific article published on April 28, 2013

Nuclear epidermal growth factor receptor is a functional molecular target in triple-negative breast cancer

scientific article

O-6-methylguanine-deoxyribonucleic acid methyltransferase methylation enhances response to temozolomide treatment in esophageal cancer

scientific article

Overcoming acquired resistance to cetuximab by dual targeting HER family receptors with antibody-based therapy

scientific article

Overexpression of the μ-Opioid Receptor in Human Non-Small Cell Lung Cancer Promotes Akt and mTOR Activation, Tumor Growth, and Metastasis ⬇️

scientific article published on April 1, 2012

PAX3 and FOXD3 Promote CXCR4 Expression in Melanoma

scientific article

PAX3 and SOX10 activate MET receptor expression in melanoma

scientific article

PAX5 is expressed in small-cell lung cancer and positively regulates c-Met transcription

scientific article

PAX6 is expressed in pancreatic cancer and actively participates in cancer progression through activation of the MET tyrosine kinase receptor gene

scientific article published on 03 August 2009

PI3 Kinase Pathway and MET Inhibition is Efficacious in Malignant Pleural Mesothelioma

scientific article published on 13 September 2016

Paxillin expression and amplification in early lung lesions of high-risk patients, lung adenocarcinoma and metastatic disease

scientific article

Paxillin is a target for somatic mutations in lung cancer: implications for cell growth and invasion

scientific article

Paxillin mutations affect focal adhesions and lead to altered mitochondrial dynamics: relevance to lung cancer

scientific article

Personalized Treatment of Lung Cancer ⬇️

scientific article published on April 1, 2011

Phase 1 Study of Accelerated Hypofractionated Radiation Therapy With Concurrent Chemotherapy for Stage III Non-Small Cell Lung Cancer: CALGB 31102 (Alliance).

scientific article published on 31 January 2018

Phase 2 trial of Linifanib (ABT-869) in patients with advanced non-small cell lung cancer

scientific article published on August 2011

Phase I dose-escalation study of onartuzumab as a single agent and in combination with bevacizumab in patients with advanced solid malignancies

scientific article published on 3 February 2014

Phase I trial of erlotinib-based multimodality therapy for inoperable stage III non-small cell lung cancer

scientific article

Phase II Study of the AKT Inhibitor MK-2206 plus Erlotinib in Patients with Advanced Non-Small Cell Lung Cancer Who Previously Progressed on Erlotinib

scientific article

Phase II study of amrubicin as second-line therapy in patients with platinum-refractory small-cell lung cancer

scientific article

Phase II study of imatinib in patients with small cell lung cancer.

scientific article published on December 2003

Post-crizotinib management of effective ceritinib therapy in a patient with ALK-positive non-small cell lung cancer

scientific article

Preclinical studies of the proteasome inhibitor bortezomib in malignant pleural mesothelioma

scientific article published on 24 May 2007

Prognostic and Predictive Value in KRAS in Non-Small-Cell Lung Cancer: A Review

scientific article

Prognostic and predictive value of circulating tumor cells and CXCR4 expression as biomarkers for a CXCR4 peptide antagonist in combination with carboplatin-etoposide in small cell lung cancer: exploratory analysis of a phase II study

scientific article

Prognostic significance of angiogenesis and angiogenic growth factors in nonsmall cell lung cancer ⬇️

scientific article published on February 24, 2011

Prognostic value of metabolic tumor burden on 18F-FDG PET in nonsurgical patients with non-small cell lung cancer

scientific article published on 23 September 2011

Prostate-Associated Gene 4 (PAGE4): Leveraging the Conformational Dynamics of a Dancing Protein Cloud as a Therapeutic Target.

scientific article published on 17 June 2018

Protein kinase C beta in malignant pleural mesothelioma

scientific article published on October 2008

Proteomic characterization of non-small cell lung cancer in a comprehensive translational thoracic oncology database ⬇️

scientific article published on February 28, 2011

Quality of Life After Radical Pleurectomy Decortication for Malignant Pleural Mesothelioma ⬇️

scientific article published on August 24, 2012

RON(MST1R)is a novel prognostic marker and therapeutic target for gastroesophageal adenocarcinoma ⬇️

scientific article published on July 1, 2011

ROS1 rearranged non-small cell lung cancer brain metastases respond to low dose radiotherapy

scientific article published on 6 July 2015

Randomized Phase Ib/II Study of Gemcitabine Plus Placebo or Vismodegib, a Hedgehog Pathway Inhibitor, in Patients With Metastatic Pancreatic Cancer

scientific article published on 2 November 2015

Randomized phase II Study of carboplatin and etoposide with or without the bcl-2 antisense oligonucleotide oblimersen for extensive-stage small-cell lung cancer: CALGB 30103.

scientific article published on February 2008

Rapid and dramatic radiographic and clinical response to an ALK inhibitor (crizotinib, PF02341066) in an ALK translocation-positive patient with non-small cell lung cancer

scientific article published on December 2010

Recent advances in the molecular biology, diagnosis and novel therapies for various small blue cell tumors.

scientific article

Receptor tyrosine kinases and inhibitors in lung cancer.

scientific article

Regulation of cellular proliferation, cytoskeletal function, and signal transduction through CXCR4 and c-Kit in small cell lung cancer cells

scientific article published on November 2002

Reliable and sensitive identification of occult tumor cells using the improved rare event imaging system

scientific article published in May 2004

Review of clinic trials: agents targeting c-Met

scientific article published on May 2007

Role of MetMAb (OA-5D5) in c-MET active lung malignancies

scientific article published on December 2011

Role of PAX8 in the regulation of MET and RON receptor tyrosine kinases in non-small cell lung cancer

scientific article

Role of c-Met in cancer: emphasis on lung cancer

scientific article

Role of c-Met/phosphatidylinositol 3-kinase (PI3k)/Akt signaling in hepatocyte growth factor (HGF)-mediated lamellipodia formation, reactive oxygen species (ROS) generation, and motility of lung endothelial cells

scientific article

Role of protein kinase C β and vascular endothelial growth factor receptor in malignant pleural mesothelioma: Therapeutic implications and the usefulness of Caenorhabditis elegans model organism ⬇️

scientific article published on 03 March 2011

Role of receptor tyrosine kinases in lung cancer

scientific article

Role of the hepatocyte growth factor receptor, c-Met, in oncogenesis and potential for therapeutic inhibition ⬇️

scientific article (publication date: February 2002)

Role played by paxillin and paxillin tyrosine phosphorylation in hepatocyte growth factor/sphingosine-1-phosphate-mediated reactive oxygen species generation, lamellipodia formation, and endothelial barrier function

scientific article

Small Cell Lung Cancer: Can Recent Advances in Biology and Molecular Biology Be Translated into Improved Outcomes?

scientific article published on 29 January 2016

Small cell lung cancer: from molecular biology to novel therapeutics

scientific article published on November 2003

Small-cell cancers, and an unusual reaction to chemotherapy. Case 1. Extrapulmonary small-cell carcinoma arising in the prostate

scientific article published on 01 June 2003

Sphingosine kinase 1 is required for mesothelioma cell proliferation: role of histone acetylation

scientific article

Stamp out lung cancer

scientific article published on January 2008

State-of-the-art considerations in small cell lung cancer brain metastases

scientific article published on 18 July 2017

Stereotactic body radiation therapy (SBRT) for early-stage lung cancer in the elderly

scientific article published on 01 July 2018

Synergism of EGFR and c-Met pathways, cross-talk and inhibition, in non-small cell lung cancer

scientific article published on January 2008

Systemic therapies in the treatment of non-small-cell lung cancer brain metastases

scientific article published on 18 February 2016

TLR3 agonists and proinflammatory antitumor activities ⬇️

scientific article published on March 19, 2013

TOPK (T-LAK cell-originated protein kinase) inhibitor exhibits growth suppressive effect on small cell lung cancer

scientific article published on 11 January 2017

Targeted agents in non-small cell lung cancer therapy: What is there on the horizon? ⬇️

scientific article published on March 18, 2013

Targeted molecules in small cell lung cancer

scientific article published on February 2004

Targeting ALK: a promising strategy for the treatment of non-small cell lung cancer, non-Hodgkin's lymphoma, and neuroblastoma

scientific article published on 12 September 2012

Targeting c-Kit mutations: basic science to novel therapies

scientific article published on May 2004

Targeting myeloid-derived suppressor cells augments antitumor activity against lung cancer

scientific article

Teaching Video Neuro Images : Myokymia and nerve hyperexcitability as components of Morvan syndrome due to malignant thymoma ⬇️

scientific article published on January 29, 2013

Temozolomide and/or Erlotinib in the Treatment of Lung Cancer Patients With Progressive Central Nervous System Metastases ⬇️

scientific article published on February 1, 2012

The American Association for Thoracic Surgery guidelines for lung cancer screening using low-dose computed tomography scans for lung cancer survivors and other high-risk groups

scientific article

The Chicago Thoracic Oncology Database Consortium: A Multisite Database Initiative

scientific article published on 16 March 2016

The EphB4 receptor tyrosine kinase promotes lung cancer growth: a potential novel therapeutic target

scientific article published on 2 July 2013

The Genetic/Non-genetic Duality of Drug 'Resistance' in Cancer

scientific article published on 3 February 2018

The MET axis as a therapeutic target

scientific article

The MET receptor tyrosine kinase is a potential novel therapeutic target for head and neck squamous cell carcinoma

scientific article

The Mu opioid receptor promotes opioid and growth factor-induced proliferation, migration and Epithelial Mesenchymal Transition (EMT) in human lung cancer

scientific article

The accelerated path of ceritinib: Translating pre-clinical development into clinical efficacy

scientific article

The brigatinib experience: a new generation of therapy for ALK-positive non-small-cell lung cancer

scientific article published on 16 February 2018

The database of chromosome imbalance regions and genes resided in lung cancer from Asian and Caucasian identified by array-comparative genomic hybridization ⬇️

scientific article published on June 12, 2012

The novel role of the mu opioid receptor in lung cancer progression: a laboratory investigation

scientific article

The role of EGFR inhibition in the treatment of non-small cell lung cancer

scientific article

The role of chemokine receptor CXCR4 in lung cancer

scientific article published on 18 March 2010

The role of ephrins and Eph receptors in cancer

scientific article

The role of the c-Met pathway in lung cancer and the potential for targeted therapy ⬇️

scientific article published on July 1, 2011

Therapeutic targeting of receptor tyrosine kinases in lung cancer

scientific article

Therapeutic targeting of the receptor tyrosine kinase Met.

scientific article published on January 2004

Three-dimensional stereoscopic volume rendering of malignant pleural mesothelioma

scientific article published on January 2012

Transactivation of the receptor-tyrosine kinase ephrin receptor A2 is required for the low molecular weight hyaluronan-mediated angiogenesis that is implicated in tumor progression.

scientific article

Tumor Heterogeneity and Therapeutic Resistance

scientific article published on January 2016

Tyrosine kinase mutations in human cancer

scientific article published on February 2007

Unique fractal evaluation and therapeutic implications of mitochondrial morphology in malignant mesothelioma

scientific article published on 15 April 2016

Unique metastases of ALK mutated lung cancer activated to the adnexa of the uterus

scientific article

Unusual problems in breast cancer and a rare lung cancer case. Case 4. Primary lymphoepithelioma-like carcinoma of the lung

scientific article published in June 2003

Use of temozolomide with other cytotoxic chemotherapy in the treatment of patients with recurrent brain metastases from lung cancer

scientific article published in January 2003

Utilisation of a thoracic oncology database to capture radiological and pathological images for evaluation of response to chemotherapy in patients with malignant pleural mesothelioma

scientific article

Vaccination with irradiated autologous tumor cells engineered to secrete granulocyte-macrophage colony-stimulating factor augments antitumor immunity in some patients with metastatic non-small-cell lung carcinoma

scientific article published on 01 February 2003

Value-Based Medicine and Integration of Tumor Biology

scientific article published in January 2017

Value-based genomics.

scientific article

Vascular Endothelial Growth Factor-induced Migration of Multiple Myeloma Cells Is Associated with β1 Integrin- and Phosphatidylinositol 3-Kinase-dependent PKCα Activation ⬇️

scientific article published on December 20, 2001

Vitamin D receptor expression in normal, premalignant, and malignant human lung tissue

scientific article published on May 2008

Whole-animal mounts of Caenorhabditis elegans for 3D imaging using atomic force microscopy

scientific article

c-Abl mediated tyrosine phosphorylation of paxillin regulates LPS-induced endothelial dysfunction and lung injury

scientific article published on 20 March 2015

c-MET mutational analysis in small cell lung cancer: novel juxtamembrane domain mutations regulating cytoskeletal functions ⬇️

scientific article published on October 1, 2003

c-Met and hepatocyte growth factor: potential as novel targets in cancer therapy

scientific article published on March 2007

c-Met as a target for human cancer and characterization of inhibitors for therapeutic intervention

scientific article

c-Met inhibition.

scientific article published on November 2006

c-Met is a potentially new therapeutic target for treatment of human melanoma

scientific article published on April 2007

c-Met: structure, functions and potential for therapeutic inhibition

scientific article (publication date: December 2003)

Paulina is supported by:

About Paulina

Help